Please login to the form below

Ashfield announces leadership changes in the U.S. and Japan.

Ashfield announces the appointment of Greg Flynn as Regional President of Commercial and Clinical in the U.S. and Mick O’Leary as Regional President of Commercial and Clinical in Japan, where he will lead CMIC Ashfield.

Greg Flynn will oversee U.S. operations of Commercial, Clinical, Medical Information, Pharmacovigilance and Market Access. Greg is transitioning to this role from his prior position as Regional President in Japan and Representative Director of CMIC Ashfield, a joint initiative between CMIC Holdings Co., Ltd and UDG Healthcare plc. Under Greg’s leadership, Ashfield became an industry leading partner with over 650 staff across 44 clients in five years.



Mick O’Leary will take over the role as Regional President in Japan, leading the CMIC Ashfield joint venture. Mick was previously the Managing Director for Ashfield Ireland, and has over 20 years’ experience in the pharmaceutical sales industry. Under Mick’s leadership, Ashfield has been established as the Number 1 CSO in Ireland with over 60% market share.



Commenting on his appointment, Greg Flynn said: “Through the talent of our people and Ashfield’s commitment to helping improve lives, I have seen the power of what we do in this organisation. The U.S. business has experienced phenomenal growth in the last two years and this new role is an exciting opportunity to continue that growth. I am excited about the future of Ashfield in the U.S. and being part of the next phase in this company’s journey.”

Mick O’Leary commented, “I am delighted to accept the role of Regional President in Japan and support the group’s overall strategy of expansion in growth markets. CMIC Ashfield is a winning proposition, combining the experience and expertise of a leading international CSO, with the local knowledge and capability of one of Japan’s leading CSOs. We’ll continue to excel by providing flexible, evidence-based services and I look forward to working with new clients and brand challenges in Japan.”

Julian Tompkins, Global President for Ashfield Clinical and Commercial business also commented: “We are delighted to have appointed these critical roles for the business. Greg’s leadership in the Japanese market has yielded remarkable growth and proven his dedication to Ashfield’s success. With Greg’s innovative thinking and focus on people, we are looking forward to seeing his impact on the U.S. business.

The appointment of Mick O’Leary as Regional President in Japan will continue our success story and excellent results in the second largest global pharmaceutical market. He has exactly the right expertise and drive to lead CMIC Ashfield and continue our strong progress in Japan.”

For more information on Ashfield services visit ashfieldhealthcare.com or for questions on this article contact jane.neale@ashfieldhealthcare.com.


15th June 2017

Share

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

Eoin McAtamney announced as Managing Director of Ashfield Ireland
Ashfield Ireland is delighted to welcome Eoin McAtamney as Managing Director.
Ashfield
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little air-time, even within the industry, let alone outside of it. As the dust settles and numbers are crunched, we should now be able to benchmark against the inaugural data, giving it more significance, relevance and validity.
Ashfield
Ashfield to host webinar on Patient Support Programmes on Tuesday 10 October
Nagore Fernandez, Ashfield’s Head of Patient Services for Europe, shares what it takes to launch and measure a successful patient support programme.
Ashfield
The 7 biggest risks to e-detailing success
E-detailers promote medicines to healthcare professionals (HCPs) over the phone and via online platforms, such as WebEx. It’s a fast-growing channel but there are common mistakes which prevent it reaching its full potential. Download our infographic to see the biggest risks with the service, and see our top tips to avoid them!
Ashfield
Patient support blog series: Step 3 to a successful patient support programme

Ashfield
Patient support blog series: Step 2 to a successful patient support programme
Break down those silos and work across internal and external stakeholders!
Ashfield